Coronaviruses are a type of virus. There are many different kinds, and some cause disease. A newly identified coronavirus, SARS-CoV-2, has caused a worldwide pandemic of respiratory illness, called COVID-19, that was first identified in December 2019. The new coronavirus can be spread from person to person. Diagnosis may be difficult with only a physical exam because mild cases of COVID-19 may appear similar to the flu or a bad cold. A laboratory test can confirm the diagnosis. There are several types of tests measuring different things, and new innovations and strategies are emerging all the time. Nasal and throat swabs are uncomfortable—and that’s particularly problematic for those who have to get tested frequently—so our research center in Jakarta, named Stem Cell and Cancer Institute (SCI) of Kalbe, are studying and produce innovation Covid-19 test that less invasive methods with saliva tests, it is a promising alternative that could simplify and accelerate COVID-19 diagnosis. The results of this research were produced by PT KalGen DNA and marketed by PT Enseval Medika Prima (EMP), under the name ELVA Diagnostic SARS-CoV-2 Saliva Nucleic Acid Test Kit. ELVA Diagnostic SARS-CoV-2 Saliva Nucleic Acid Test Kit has received distribution authorization from Kementerian Kesehatan Republic of Indonesia with number KEMKES RI AKD 20303120508.